Site Search

... and comprehensive health insurance including Medicaid and will support efforts to curb the availability of inadequate health plans.  Access to Biomarker Testing:  ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... barriers that inhibit people from completing the screening process.   Helping patients avoid ineffective treatment through increased access to biomarker testing: “Biomarker testing provides doctors with information about what treatment their patients will best respond to, helping patients more effectively and ...

... and will oppose proposals that create barriers to care for cancer patients, survivors, and those who could be diagnosed with cancer. Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... insurance can find themselves with medical debt. The problem for these patients is that their insurance may not cover medically appropriate testing and treatments. This forces many New Jerseyans to choose between their physical and financial health. For example, some health insurance plans may not cover the biomarker testing that a patient needs. This testing is a game-changer in the fight against cancer and an essential step in accessing precision ... looking to change that and increase access to this revolutionary testing by requiring state-regulated health plans, including Medicaid, to cover biomarker testing for patients who can benefit. “As we pursue the aforementioned opportunities to assist current patients, we must also consider ...